Alzheimer’s Drug Demonstrates Good Tolerability Beyond Clinical Trials
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
Here are a few options, all within 8 words:
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine